Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Foot Odor Control Powder
Generic Name
Tolnaftate
Active Ingredient
TolnaftateCategory
Corticosteroid [EPC]
Variants
2
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 10 mg/g | AEROSOL, SPRAY | TOPICAL | 79481-0622 |
| 1.3 g/113g | AEROSOL, SPRAY | TOPICAL | 56104-252 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Foot Odor Control Powder, you must consult a qualified healthcare professional.
Detailed information about Foot Odor Control Powder
Tolnaftate is a synthetic thiocarbamate antifungal agent used topically to treat and prevent superficial fungal infections, including athlete's foot, jock itch, and ringworm. It is a mainstay in dermatological therapy for its efficacy and safety profile.
For most fungal infections, the standard dosage is a thin layer of Tolnaftate 1% applied to the affected area twice daily (morning and night). Treatment duration typically lasts 2 to 4 weeks depending on the severity and type of infection. For the prevention of athlete's foot, the powder or spray may be used once or twice daily.
Tolnaftate is generally considered safe for children aged 2 years and older when used as directed. For children under 2 years of age, there is no established dosage, and a pediatrician must be consulted before use.
Due to the negligible systemic absorption of topical Tolnaftate, no dosage adjustments are required for patients with renal insufficiency.
No dosage adjustments are necessary for patients with liver disease.
Standard adult dosing is appropriate for elderly patients, though skin integrity should be monitored to prevent excessive irritation.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next application, skip the missed dose and resume your regular schedule. Do not double the amount applied to catch up.
Systemic overdose is highly unlikely with topical use. If the medication is accidentally ingested, contact a Poison Control Center or seek emergency medical help immediately. Symptoms of ingestion may include gastric upset or nausea.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Tolnaftate is generally well-tolerated. The most common side effects are localized to the site of application and may include:
Tolnaftate is for external use only. It should never be used in the eyes, mouth, or vagina. If the medication comes into contact with the eyes, rinse thoroughly with cool water. Patients should be aware that fungal infections are contagious; avoid sharing towels or footwear during treatment.
No FDA black box warnings for Tolnaftate.
There are no known drug combinations that are strictly contraindicated with topical Tolnaftate. However, it should not be applied simultaneously with other topical agents to the same area of skin unless directed by a physician.
While systemic interactions are unlikely, the use of Tolnaftate alongside topical corticosteroids may mask the signs of a spreading infection or delay the healing process. Healthcare providers should monitor for increased skin thinning or irritation.
Other topical antifungals (e.g., Clotrimazole, Miconazole) generally do not need to be used with Tolnaftate. Using multiple antifungals simultaneously may increase the risk of localized skin irritation without providing additional therapeutic benefit.
Tolnaftate is classified as FDA Pregnancy Category C. Animal reproduction studies have not been conducted, and it is unknown whether Tolnaftate can cause fetal harm when applied topically to a pregnant woman. According to the NIH (2024), it should be used during pregnancy only if clearly needed and after a risk-benefit analysis by a physician.
It is not known whether topical Tolnaftate is excreted in human milk. Because systemic absorption is minimal, the risk to a nursing infant is considered low. However, the medication should not be applied to the breast area to prevent direct ingestion by the infant.
Tolnaftate is approved for use in children 2 years of age and older. It is commonly used for athlete's foot in adolescents. It is NOT approved for the treatment of diaper rash or fungal infections in infants under 2 years old without medical advice.
Tolnaftate is a selective inhibitor of squalene epoxidase, an enzyme located in the endoplasmic reticulum of fungal cells. By inhibiting this enzyme, Tolnaftate prevents the conversion of squalene to lanosterol, a precursor of ergosterol. This results in a deficiency of ergosterol, which destabilizes the fungal cell membrane, and a buildup of squalene, which is toxic to the cell. This dual action effectively halts fungal replication.
Tolnaftate is highly lipophilic, allowing it to penetrate the stratum corneum and concentrate in the hair follicles and sweat glands. The onset of symptomatic relief (reduction in itching) often occurs within 24 to 72 hours, but complete eradication of the fungus typically requires 2 to 4 weeks of consistent application.
| Parameter | Value |
|---|---|
| Bioavailability | <0.1% (Topical) |
| Protein Binding | N/A (Minimal Systemic) |
Common questions about Foot Odor Control Powder
Tolnaftate is primarily used to treat and prevent superficial fungal infections of the skin, such as athlete's foot, jock itch, and ringworm. According to FDA-approved guidelines, it is effective against various dermatophytes including Trichophyton and Microsporum. It works by stopping the growth of fungi that cause skin irritation and redness. Many healthcare providers also recommend it as a preventive measure for people who frequently get athlete's foot from gyms or locker rooms. It is available in various forms like creams, powders, and sprays to suit different areas of the body.
The most common side effects of Tolnaftate are localized skin reactions at the site where the medication is applied. These typically include mild stinging, burning, or itching that occurs shortly after application. Some patients may also notice slight redness or skin dryness, particularly when using spray formulations that contain alcohol. These symptoms are usually temporary and do not require the discontinuation of the medication. If you experience severe blistering or an increase in swelling, you should stop use and consult your healthcare provider immediately.
Yes, you can generally drink alcohol while using Tolnaftate because it is a topical medication with negligible systemic absorption. Unlike some oral antifungal medications that can affect the liver, topical Tolnaftate does not enter the bloodstream in significant amounts. Therefore, there are no known contraindications or dangerous interactions between alcohol and this skin treatment. However, it is always wise to maintain a healthy lifestyle to support your immune system while fighting an infection. If you have concerns about alcohol and your specific health status, talk to your doctor.
Tolnaftate is classified as Pregnancy Category C, meaning its safety during pregnancy has not been fully established through large-scale human trials. While the systemic absorption through the skin is extremely low, medical experts recommend using it only if the benefits clearly outweigh the potential risks. Most healthcare providers consider it relatively low-risk for localized fungal infections, but you should always consult your obstetrician before starting any new medication. They may suggest alternative treatments or provide specific instructions for use. It is important to avoid applying it to large areas of the body during pregnancy.
While you may begin to feel relief from itching and burning within the first 24 to 48 hours, the fungal infection itself takes longer to clear. Most tinea infections require a consistent application for 2 to 4 weeks to ensure the fungus is completely eradicated. Even if your skin looks healthy after one week, you should continue the treatment for the full duration recommended by your doctor or the product label. Stopping too early can lead to a recurrence of the infection as dormant fungal spores may remain. If no improvement is seen after 4 weeks, a medical re-evaluation is necessary.
You can stop using Tolnaftate at any time, but doing so before the infection is fully cleared may cause the fungus to return. Unlike some internal medications, there is no withdrawal syndrome or 'rebound effect' associated with stopping this topical antifungal. However, clinical guidelines emphasize completing the full course of treatment—usually 14 to 28 days—to prevent the infection from becoming chronic. If you experience a severe allergic reaction, you must stop the medication immediately and seek medical help. Always discuss your treatment plan with a healthcare professional if you wish to discontinue early.
If you miss a dose of Tolnaftate, apply it as soon as you remember to maintain the consistent levels needed to inhibit fungal growth. However, if it is nearly time for your next scheduled application, it is better to skip the missed dose and simply continue with your regular routine. Do not apply a double layer of the cream or spray to make up for the missed application, as this will not speed up the healing process and may increase skin irritation. Consistency is key to successfully treating fungal infections. Setting a reminder on your phone can help you stay on track with your twice-daily applications.
No, Tolnaftate does not cause weight gain. Weight changes are typically associated with systemic medications, such as oral corticosteroids or certain antidepressants, that affect metabolism or appetite. Since Tolnaftate is applied topically to the skin and has negligible absorption into the bloodstream, it does not have the systemic reach to influence body weight. If you experience unexplained weight gain while using this medication, it is likely due to other factors or health conditions. You should discuss any significant changes in your weight with your healthcare provider for a proper evaluation.
Tolnaftate can generally be used alongside most oral medications because it does not significantly enter the systemic circulation. However, you should be cautious when using other topical creams, lotions, or ointments on the same area of skin. Applying multiple products at once can interfere with how well Tolnaftate is absorbed or may increase the risk of skin irritation. It is best to wait at least 30 minutes between applying different topical treatments. Always inform your doctor about all the medications you are using, including over-the-counter products and herbal supplements.
Yes, Tolnaftate is widely available as a generic medication and is the active ingredient in many well-known over-the-counter brands like Tinactin. Generic versions are required by the FDA to have the same strength, quality, and efficacy as the brand-name products. Choosing a generic version can often be more cost-effective while providing the same therapeutic benefits for treating athlete's foot or ringworm. You can find generic Tolnaftate in various forms, including creams, powders, and sprays, at most pharmacies and grocery stores. Consult your pharmacist to help you select the generic formulation that best fits your needs.
Other drugs with the same active ingredient (Tolnaftate)
> Warning: Stop taking Tolnaftate and call your doctor immediately if you experience any of these.
There are no known systemic long-term side effects associated with Tolnaftate. However, prolonged use beyond the recommended 4-week period without medical supervision may lead to skin sensitization or the development of resistant fungal strains.
No FDA black box warnings exist for Tolnaftate as of 2026. It is considered a low-risk topical medication when used according to label instructions.
Report any unusual symptoms to your healthcare provider.
Routine laboratory monitoring (e.g., CBC or LFTs) is not required for topical Tolnaftate use due to the lack of systemic absorption. Healthcare providers may perform a KOH prep or fungal culture if the infection is recalcitrant to treatment.
Tolnaftate has no known effect on the ability to drive or operate heavy machinery.
There are no documented interactions between topical Tolnaftate and alcohol consumption.
Treatment should be continued for the full duration prescribed, even if symptoms disappear after a few days. Premature discontinuation increases the risk of the infection returning.
> Important: Discuss all your medical conditions with your healthcare provider before starting Tolnaftate.
No significant interactions with herbal supplements like St. John's Wort or Ginkgo Biloba have been reported for the topical form of this medication.
Tolnaftate is not known to interfere with standard blood or urine laboratory tests. It does not affect the results of fungal cultures, though it should be cleaned from the skin before a sample is taken for diagnosis.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
There is limited evidence regarding cross-sensitivity, but patients allergic to other thiocarbamate chemicals (often found in certain industrial rubbers or pesticides) should use Tolnaftate with caution.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Tolnaftate.
No specific problems have been documented in the geriatric population. However, elderly patients may have thinner skin, which could potentially lead to increased localized irritation.
No dosage adjustment is required. The kidneys do not play a significant role in the clearance of topically applied Tolnaftate.
No dosage adjustment is required. Hepatic metabolism is not a factor for this topical agent.
> Important: Special populations require individualized medical assessment.
| Half-life | N/A (Topical) |
| Tmax | N/A |
| Metabolism | Minimal/None |
| Excretion | Desquamation (Skin Shedding) |
Tolnaftate belongs to the Thiocarbamate Antifungal class. It is distinct from the Azole antifungals (like Clotrimazole) and Allylamine antifungals (like Terbinafine), although its mechanism is similar to allylamines.